Hyperion DeFi, Inc.
Hyperion DeFi, Inc., an ophthalmic technology company, engages in development and commercialization of ophthalmic solutions in the United States. The company offers Optejet, a topical ophthalmic medication dispensing platform services. It has a license agreement with Bausch Health Ireland Limited to develop and commercialize MicroPine in the United States and Canada; a license agreement with Arct… Read more
Hyperion DeFi, Inc. (HYPD) - Total Assets
Latest total assets as of September 2025: $82.79 Million USD
Based on the latest financial reports, Hyperion DeFi, Inc. (HYPD) holds total assets worth $82.79 Million USD as of September 2025.
Total assets represent everything the company owns and controls, combining both current assets—like cash and cash equivalents, accounts receivable, and inventories—and non-current assets such as property, plant, equipment (PP&E), intangible assets, and long-term investments.
Hyperion DeFi, Inc. - Total Assets Trend (2020–2024)
This chart illustrates how Hyperion DeFi, Inc.’s total assets have evolved over time, based on quarterly financial data. Explore and compare other companies by total assets.
Hyperion DeFi, Inc. - Asset Composition Analysis
Current Asset Composition (December 2024)
Hyperion DeFi, Inc.'s total assets of $82.79 Million consist of 75.5% current assets and 24.6% non-current assets.
| Asset Category | Amount (USD) | % of Total Assets |
|---|---|---|
| Cash & Equivalents | $0.00 | 57.8% |
| Accounts Receivable | $24.83K | 0.7% |
| Inventory | $0.00 | 0.0% |
| Property, Plant & Equipment | $0.00 | 0.0% |
| Intangible Assets | $0.00 | 0.0% |
| Goodwill | $0.00 | 0.0% |
Asset Composition Trend (2020–2024)
This chart illustrates how Hyperion DeFi, Inc.'s asset composition has evolved over time. Understanding changes in asset allocation can provide insights into the company's strategic shifts, capital allocation priorities, and business focus evolution.
Key Asset Composition Facts
- Current vs. Non-Current Assets: Hyperion DeFi, Inc.'s current assets represent 75.5% of total assets in 2024, a decrease from 98.5% in 2020.
- Cash Position: Cash and equivalents constituted 57.8% of total assets in 2024, down from 83.7% in 2020.
- Tangible vs. Intangible: Intangible assets (including goodwill) make up 0.0% of total assets, unchanged from 0.0% in 2020.
- Asset Diversification: The largest asset category is accounts receivable at 0.7% of total assets.
Hyperion DeFi, Inc. Competitors by Total Assets
Key competitors of Hyperion DeFi, Inc. based on total assets are shown below.
| Company | Country | Total Assets |
|---|---|---|
|
Halozyme Therapeutics Inc
NASDAQ:HALO
|
USA | $2.22 Billion |
|
Biomarin Pharmaceutical Inc
NASDAQ:BMRN
|
USA | $7.59 Billion |
|
ESSA Pharma Inc
NASDAQ:EPIX
|
USA | $110.50 Million |
|
Shenzhen CAU Technology Co Ltd
SHE:000004
|
China | CN¥260.55 Million |
|
Pacific Shuanglin Bio pharmacy Co Ltd
SHE:000403
|
China | CN¥9.58 Billion |
|
Nanhua Bio Medicine Co Ltd
SHE:000504
|
China | CN¥841.96 Million |
|
Jiangsu Sihuan Bioengineering Co Ltd
SHE:000518
|
China | CN¥509.14 Million |
|
Chengzhi Shareholding Co Ltd
SHE:000990
|
China | CN¥27.52 Billion |
Hyperion DeFi, Inc. - Asset Efficiency Metrics
Asset efficiency metrics measure how effectively a company uses its assets to generate revenue and profits. These indicators help investors evaluate management's ability to deploy capital efficiently.
Asset Turnover Ratio
Measures how efficiently a company uses its assets to generate sales
Lower asset utilization - Hyperion DeFi, Inc. generates 0.02x its asset value in annual revenue.
Return on Assets (ROA)
Measures how efficiently a company uses its assets to generate profits
Negative ROA - Hyperion DeFi, Inc. is currently not profitable relative to its asset base.
Hyperion DeFi, Inc. - Liquidity and Working Capital Analysis
Liquidity ratios measure a company's ability to pay off its short-term debts as they come due, using the company's current or quick assets. Working capital represents the operational liquidity available.
Key Liquidity Metrics
| Metric | Current | 1 Year Ago | 5 Years Ago |
|---|---|---|---|
| Current Ratio | 2.25 | 0.74 | 2.17 |
| Quick Ratio | 2.25 | 0.55 | 2.16 |
| Cash Ratio | 0.00 | 0.00 | 0.00 |
| Working Capital | $5.05 Million | $ -4.09 Million | $ 11.18 Million |
Hyperion DeFi, Inc. - Advanced Valuation Insights
This section examines the relationship between Hyperion DeFi, Inc.'s asset base and its market valuation, helping to identify whether the company's assets are efficiently translated into market value.
Key Valuation Metrics
| Current Price-to-Book Ratio | 1.70 |
| Latest Market Cap to Assets Ratio | 4.53 |
| Asset Growth Rate (YoY) | -87.3% |
| Total Assets | $3.67 Million |
| Market Capitalization | $16.63 Million USD |
Valuation Analysis
Premium Asset Valuation: The market values Hyperion DeFi, Inc.'s assets at a significant premium ( 4.53x), suggesting investors see substantial growth potential or unique competitive advantages.
Significant Asset Reduction: Hyperion DeFi, Inc.'s assets decreased by 87.3% over the past year, potentially indicating divestiture, restructuring, or challenging business conditions.
Annual Total Assets for Hyperion DeFi, Inc. (2020–2024)
The table below shows the annual total assets of Hyperion DeFi, Inc. from 2020 to 2024.
| Year | Total Assets | Change |
|---|---|---|
| 2024-12-31 | $3.67 Million | -87.26% |
| 2023-12-31 | $28.78 Million | -7.27% |
| 2022-12-31 | $31.04 Million | -1.97% |
| 2021-12-31 | $31.66 Million | -6.63% |
| 2020-12-31 | $33.91 Million | -- |